Information:
Fel:
Nyckelord
N05.715.360.775.175.250.350 ×
- Clinical Trial (641)
- Breast Neoplasms (111)
- Prostatic Neoplasms (58)
- Lung Neoplasms (45)
- Colorectal Neoplasms (39)
- Laboratories (31)
- Vaccination (30)
- Leukemia (28)
- Urology (26)
- Hepatitis B Vaccines (24)
- Adverse event (23)
- Clinical Trial, Phase I (22)
- Multiple Myeloma (22)
- Registries (21)
- Electrocardiogram (ECG) (21)
- Hepatitis B (21)
- Vital Signs (19)
- End of Study (19)
- Hepatitis A (18)
- Pancreatic Neoplasms (17)
- AML (16)
- Demography (16)
- Physical Examination (15)
- Gastroenterology (15)
- Hematology (15)
- Melanoma (15)
- Brain Neoplasms (14)
- Neurology (14)
- Pregnancy (13)
- Restless Legs Syndrome (13)
- Vaccines (13)
- Hepatitis A Vaccines (13)
- Endometrial Neoplasms (12)
- Clinical Trial, Phase III (12)
- Malaria Vaccines (12)
- Drug trial (12)
- Lymphoma, Non-Hodgkin (12)
- Central Nervous System Neoplasms (11)
- Uterine Cervical Neoplasms (11)
- Type 2 Diabetes (11)
- Malaria (11)
- Medical History Taking (11)
- Urinary Bladder Neoplasms (10)
- Concomitant Medication (10)
- Diabetes Mellitus, Type 2 (10)
- Clinical Trial, Phase II (9)
- Head and Neck Neoplasms (9)
- Neoplasms (9)
- Lost to Follow-Up (8)
- Eligibility Determination (8)
- Alzheimer Disease (8)
- Medical Oncology (8)
- Pediatrics (8)
- Pulmonary Medicine (7)
- Haemophilus influenzae type b (7)
- Document Tracking (7)
- Patient Participation (7)
- Asthma (6)
- Urinalysis (6)
- Clinical Trial, Phase IV (6)
- Clinical Chemistry Tests (6)
- Cerebral Palsy (6)
- Routine documentation (6)
- Death (6)
- Fallopian Tube Neoplasms (6)
- Gynecology (6)
- Anemia, Aplastic (6)
- Pharmacokinetics (5)
- Psychiatry (5)
- Survival (5)
- Leukemia, Myeloid, Chronic-Phase (5)
- Pulmonary Disease, Chronic Obstructive (5)
- Stem Cell Transplantation (5)
- Neoplasms, Plasma Cell (5)
- Leukemia, Myelomonocytic, Juvenile (5)
- Drug-Related Side Effects and Adverse Reactions (5)
- On-Study Form (5)
- Released Standard (5)
- HIV (5)
- Informed Consent (5)
- Kidney Neoplasms (5)
- Fabry Disease (5)
- Liver Neoplasms (5)
- Myelodysplastic Syndromes (5)
- Ophthalmology (5)
- Placebos (4)
- Respiratory Function Tests (4)
- Sarcoma, Kaposi (4)
- Therapeutics (4)
- Leukemia, B-Cell (4)
- Leukemia, Lymphocytic, Chronic, B-Cell (4)
- Lymphoma, B-Cell (4)
- Hypereosinophilic Syndrome (4)
- Blood (4)
- Cardiology (4)
- Gastrointestinal Stromal Tumors (4)
- Parkinsons Disease (4)
- Scores & Instruments (4)
- Endocrinology (4)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
730 Sökresultat.
Item-grupper: Header Module, Header, ON TREATMENT, OFF TREATMENT, Section I, Section II MEASURABLE LESIONS, T2/FLAIR, T1/Contrast, Section III - Lesions Reported as Non-Measurable at Baseline, T2/FLAIR , T1/Contrast, Section IV New CNS Lesions/New Enhancement of Previously Reported Lesions, T2/FLAIR, T1/Contrast, Section V Progression, Comments
Item-grupper: General information, Reporting Period, Footer Module
Item-grupper: Header, Unnamed Module, VITAL STATUS, Disease Follow-up Status, Notice of First Relapse/Progression, Notice of New Primary, Late Adverse Event, Late Adverse Events
Item-grupper: MSKCC 00-138; CALGB-90104; ECOG, Form Administration, Vital Status, Disease Follow-Up Status, Notice of Progression, Notice of New Primary, Notice of Long Term Toxicity, Comments, CCRR MODULE
Item-grupper: CRF Header, MELANOMA: VITAL STATUS, MELANOMA: DISEASE FOLLOW-UP STATUS, MELANOMA: NOTICE OF PROGRESSION, MELANOMA: NON-PROTOCOL THERAPY, MELANOMA: NOTICE OF NEW PRIMARY, MELANOMA: LONG-TERM TOXICITY, Comments
Item-grupper: CRF Header, BLADDER: FORM ADMINISTRATION, BLADDER: VITAL STATUS, BLADDER: DISEASE FOLLOW-UP STATUS, BLADDER: SUPERFICIAL DISEASE FOLLOW-UP ASSESSMENT, BLADDER: NOTICE OF PROGRESSION, BLADDER: NOTICE OF NEW PRIMARY, BLADDER: LONG-TERM TOXICITY, Comments
Item-grupper: CRF Header, GI: VITAL STATUS, GI: DISEASE FOLLOW-UP STATUS, GI: NOTICE OF PROGRESSION, GI: NOTICE OF NEW PRIMARY, Comments
Item-grupper: Header Module, OFF TREATMENT, Header, ECOG Performance Status, Section I - Vital Status, Section II - Reporting Period, Section III - Notice of New Primary, Section IV - Disease Follow-up Status, Section V - Salvage Therapy, Section VI - BRAF Mutation, Section VI - Adverse Events, Section VII - Non-Protocol Therapy Prior To Progression, Footer Module
Item-grupper: Header, Vital Status, Disease Assessment, Notice of Progression, Postoperative Therapy, Postoperative Therapy (continued), Notice of New Primary, Long-Term Toxicity, Footer
Item-grupper: Header Module, Patient Information, Disease Status, Progression/Relapse Data, Progression/Relapse Data2, NON-PROTOCOL TREATMENT, Footer
Item-grupper: Header, Vital Status, Treatment Status, Current Supplements, Notice of Skeletal Related Event, Disease Follow-Up Status, Notice Of Progression, Notice of New Primary, Non-Protocol Therapy, Footer
Item-grupper: Header Module, LONG TERM FOLLOW-UP, Footer Module